Pfizer | PFE - Zysk Brutto Na Sprzedaży

Cena Akcji
26.97
Dzienna Zmiana
-0.44 -1.61%
Miesięcznie
-0.33%
Rocznie
2.63%
Q1 Prognozy TE
26.16




Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 10.47B 605M 2025-09
Abbott USD 6.54B 625M 2025-12
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.48B 307M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 8.7M 853K 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Glaxosmithkline GBP 8.75B 2.92B 2025-09
J&J USD 16.6B 118M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merck USD 13.42B 431M 2025-09
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Sanofi EUR 8.45B 3.02B 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Zoetis USD 1.64B 73M 2025-12